Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Future Infectious Disease Nucleic Acid Testing


News provided by

Reportlinker

Feb 16, 2012, 06:44 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Feb. 16, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Future Infectious Disease Nucleic Acid Testing

http://www.reportlinker.com/p0773575/Future-Infectious-Disease-Nucleic-Acid-Testing.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

This 360-page report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.

Contains 360 pages and 20 tables

Table of Contents

2. Major Infectious Diseases

* AIDS

O Structure and Composition

O Classification

O AIDS Origins

O Animal Lentivirus Systems

O Virus Receptors

O HIV Infections in Humans

- Pathogenesis and Pathology

O CD4T Lymphocytes and Memory Cells

O Monocytes and Macrophages

O Lymphoid Organs

O Neural Cells

O Viral Coinfections

- Clinical Findings

O Plasma Viral Load

O Pediatric AIDS

- Neurologic Disease

- Opportunistic Infections

- Cancer

O Immunity

- Virus Isolation

- Serology

- Viral Nucleic Acid/Antigen Detection

O Epidemiology

- Worldwide Spread of AIDS

- United States

- Routes of Transmission

O DNA Probes- Overview- Quantitative PCR- In Situ PCR- Needed ImprovementsO Viral Load/Drug Resistance TestingO Genotype and Phenotype TestingO Blood Banking Considerations* AdenovirusO BackgroundO Diagnostic TestsO Vaccines and DrugsO Adeno-Associated Viruses (AAV)* Anthrax/Bacillus AnthracisO BackgroundO Diagnostic TestsO Vaccines and Drugs* BabesiosisO Background* BEA and Other Bartonella DiseasesO BackgroundO Diagnostic TestsO Vaccines and Drugs* Chagas DiseaseO Background* CampylobacterO BackgroundO Diagnostic Tests- Culture IdentificationO Vaccines and Drugs* ChlamydiaO Background- Chlamydia psittaci- Chlmaydia pneumoniae- Chlamydia trachomatisO Diagnostic TestsO Vaccines and Drugs* Creutzfeldt-Jakob's DiseaseO BackgroundO Blood TransmissionO Diagnostic Tests

O Major Commercial and Academic Players

- Bayer

- Disease Sciences/Bio Tec Global

- Imperial College School of Medicine

- Ortho-Clinical Diagnostics

- Pall

- ProMetic Life Sciences

- Proteome Sciences/Idexx

- Q-One Biotech

- Serono

- U.S. Agricultural Research Service

O Drugs

O Vaccines

* Cytomegalovirus

O Background

- Chorioretinitis

- Gastrointestinal

- Central Nervous System Disease

O Diagnostic Tests

O Vaccines and Drugs

* Ebola Virus

O Background

- Epidemiology

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* EchoVirus

O Background

- Acute Aseptic Meningitisis

- Encephalitis

- Exanthems

- Respiratory Disease

- Myopericarditis

- Neonatal Infections

O Diagnostic Tests

O Vaccines and Drugs

* Encephalitis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* EnterovirusesO BackgroundO Diagnostic Tests- Viral Isolation and Identification- Antibody TestsO Vaccines and Drugs* Epstein-Barr VirusO BackgroundO Diagnostic TestsO Vaccines and Drugs* GonorrheaO BackgroundO Diagnostic TestsO Vaccines and Drugs* HepatitisO Hepatitis AO Hepatitis B- Structure and Composition- ReplicationO Hepatitis CO Hepatitis D (Delta)O Hepatitis EO Hepatitis GO Hepatitis Infections PathologyO Clinical FindingsO Laboratory Tests- Hepatitis A- Hepatitis B- Hepatitis C- Hepatitis D- Hepatitis EO Virus-Host Immune ReactionsO Epidemiology- Hepatitis A- Hepatitis B- Hepatitis C- Hepatitis D (Delta)O Vaccines and Drugs

* Herpes Simplex Virus

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Legionella

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Lyme Disease

O Background

- Clinical Description

- Clinical Case Definition

- Laboratory Criteria for Diagnosis

- Case Classification

O Diagnostic Tests

O Vaccines and Drugs

* Malaria

* Mycoplasma

O Background

- Ureaplasma Urealyticum & Mycoplasma

Hominis

O Diagnostic Tests

O Vaccines and Drugs

* Papillomaviruses/HPV

O Background

- HPV in Cancer

- Cervical Neoplasm

O Diagnostic Tests

O Vaccines and Drugs

- Prevention

* Parvovirus B19

O Background

- Microbiology

- Epidemiology

- Clinical Syndromes

- Erythema Infectiosum (Slapped Cheek)

- Adult Polyarthropathy

- Transient Aplastic Crisis

- Transient Pancytopenia

- Red Cell Aplasia in Immunocompromised- Perinatal InfectionsO Diagnostic TestO Vaccines and Drugs* PneumoniaO BackgroundO Diagnostic TestsO Vaccines and Drugs* PolyomavirusesO BackgroundO Diagnostic TestsO Vaccines and Drugs* SalmonellosisO BackgroundO Diagnostic TestsO Vaccines and Drugs* ShigellosisO BackgroundO Diagnostic TestsO Vaccines and Drugs* StreptococciO BackgroundO Diagnostic TestsO Vaccines and Drugs- Group A Streptococci- Group B Streptococci* ToxoplasmosisO BackgroundO Diagnostic TestsO Vaccines and Drugs* TuberculosisO BackgroundO Diagnostic Tests- Microscopic Characteristics- Cultural Characteristics- Skin Tests- MDRTBO Vaccines and Drugs

* West Nile Virus

O Background

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* Yersinia

O Background

O Diagnostic Tests

O Vaccines and Drugs

3. Antibiotic Susceptibility

List of Tables

AIDS NAT and other Direct

Identification Tests

Table 2: Major Companies Developing or Marketing

Adenovirus NAT and other

Direct Identification Tests

Table 3: Major Companies Developing or Marketing

Campylobacter NAT and

Other Direct Identification Tests

Table 4: Major Companies Developing or Marketing

Chlamydia NAT and other

Direct Identification Tests

Table 5: Major Companies Developing or Marketing

CMV NAT and other Direct

Identification Tests

Table 6: Major Companies Developing or Marketing

EBV NAT and other Direct

Identification Tests

Table 7: Major Companies Developing or Marketing

Gonorrhea NAT and other

Direct Identification Tests

Table 8: Major Companies Developing or Marketing

Hepatitis NAT and other

Direct Identification Tests

Table 9: Major Companies Developing or Marketing

Herpes NAT and other

Direct Identification Tests

Table 10: Major Companies Developing or Marketing

Legionella NAT and other

Direct Identification Tests

List of Tables (continued)

Table 11: Major Companies Developing or Marketing

Lyme Disease NAT

And Other Direct Identification Tests

Table 12: Major Companies Developing or Marketing

Mycoplasma NAT

And other Direct Identification Tests

Table 13: Major Companies Developing or Marketing

Papilloma Virus NAT

And Other Direct Identification Tests

Table 14: Major Companies Developing or Marketing

Pneumonia NAT

And other Direct Identification Tests

Table 15: Major Companies Developing or Marketing

Salmonella NAT

And other Direct Identification Tests

Table 16: Major Companies Developing or Marketing

Shigella NAT

And other Direct Identification Tests

Table 17: Major Companies Developing or Marketing

Streptococci NAT

And Other Direct Identification Tests

Table 18: Major Companies Developing or Marketing

Toxoplasmosis NAT

And Other Direct Identification Tests

Table 19: Major Companies Developing or Marketing

Tuberculosis NAT

And Other Direct Identification Tests

To order this report:: Future Infectious Disease Nucleic Acid Testing

More  

Market Research Report

Check our  

Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.